TRADING UPDATES: Esken's Southend Airport faces further allegations | Finance News shareprices.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shareprices.com Daily Mail and Mail on Sunday newspapers.
Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T product candidate for the treatment of blood.
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Downing Renewables & Infrastructure - investor in solar.
TRADING UPDATES: Esken's Southend Airport faces further allegations lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.